● Recruiting

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

Condition: Hemophilia B · Sponsor: CSL Behring

PhaseN/A

Planned participants500

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This observational, post-authorization, long-term follow-up study aims to investigate the short and long-term effectiveness and safety of HEMGENIX in patients with hemophilia B. The study will also include a cohort of patients with hemophilia B treated with FIX prophylaxis to enable interpretation of relevant efficacy and safety findings of HEMGENIX.

This description comes directly from the study's public registry record.

Talk to the study team

Trial Registration Coordinator · +1 610-878-4697 · clinicaltrials@cslbehring.com

Always discuss trial participation with your own doctor first.

Locations (12)

American Thrombosis and Hemostasis Network	Rochester, New York, United States	Recruiting
Medical University Vienna	Vienna, Austria	Recruiting
Aarhus Universitetshospital	Århus N, Denmark	Recruiting
Centre Hospitalier Universitaire de Brest / CHU Morvan	Brest, France	Recruiting
Centre Régional de Traitement de l'Hémophilie	Nantes, France	Recruiting
CHU Nancy - Hôpital Brabois	Vandœuvre-lès-Nancy, France	Recruiting
Klinik für Angiologie/ Hämostaseologie	Berlin, Germany	Recruiting
University of Clinic Bonn	Bonn, Germany	Recruiting
Klinikum der Johann-Wolfgang Goethe Universitaet	Frankfurt, Germany	Recruiting
Hannover Medical School	Hanover, Germany	Recruiting
Hospital Alvaro Cunqueiro Dr. Manuel Rodriquez-Lopez	Vigo, Spain	Recruiting
University Hospital Bern Inselspital	Bern, Switzerland	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06008938